Pear Therapeutics

Hu Hongjie

Temasek International LLC

Hongjie (HJ) Hu is a member of the healthcare investment team at Temasek, where he covers medtech, diagnostics and digital health private and public investments. Private healthcare investments he has led include Verily, Akili, Arterys, Guardant, and Helix. He is also active with healthcare US-China cross border investments. Previously HJ was in technology and services private equity and venture capital at Bain Capital, H.I.G Capital and Crosslink Capital. He started his career in operating roles at fintech companies Tradenable and Valicert. HJ graduated with a BS/MS from Stanford and an MBA from Harvard.